Mod­er­na ex­pands pipeline to in­clude liv­er dis­ease pro­grams; Im­pe­r­i­al re­searchers team up with Hep­tares on gas­troin­testi­nal dis­eases

→ Mod­er­na‘s pipeline now in­cludes 19 mR­NA drug can­di­dates, in­clud­ing two new liv­er dis­ease pro­grams and 10 drugs in the clin­ic. New pro­grams in­clude mR­NA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.